Tug Of War In Ariad Pharmaceuticals

By: via Benzinga
When investing in the biotech and the pharmaceutical arena, there are always plenty of surprises. Following the announcement of drug trials by the FDA, there can be wild price fluctuations in an issue's price. Many of the smaller companies are also the targets of the big pharma that are looking to
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.